COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 169 filers reported holding COHERUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $139,000 | +18.8% | 36,988 | +35.3% | 0.00% | – |
Q2 2023 | $117,000 | -35.7% | 27,329 | +2.5% | 0.00% | – |
Q1 2023 | $182,000 | -26.6% | 26,652 | -14.9% | 0.00% | – |
Q4 2022 | $248,000 | -13.0% | 31,303 | +5.8% | 0.00% | – |
Q3 2022 | $285,000 | -0.7% | 29,589 | -25.5% | 0.00% | – |
Q2 2022 | $287,000 | -14.6% | 39,726 | +53.1% | 0.00% | – |
Q1 2022 | $336,000 | -37.2% | 25,942 | -22.7% | 0.00% | – |
Q4 2021 | $535,000 | +31.1% | 33,549 | +32.0% | 0.00% | – |
Q3 2021 | $408,000 | -20.9% | 25,422 | -31.7% | 0.00% | – |
Q2 2021 | $516,000 | -13.0% | 37,222 | -8.3% | 0.00% | – |
Q1 2021 | $593,000 | -30.3% | 40,576 | -17.2% | 0.00% | – |
Q4 2020 | $851,000 | +9.0% | 49,011 | +15.0% | 0.00% | – |
Q3 2020 | $781,000 | +11.4% | 42,621 | +8.7% | 0.00% | – |
Q2 2020 | $701,000 | +19.8% | 39,223 | +8.7% | 0.00% | – |
Q1 2020 | $585,000 | -30.4% | 36,070 | -22.7% | 0.00% | – |
Q4 2019 | $840,000 | -9.1% | 46,678 | +2.4% | 0.00% | – |
Q3 2019 | $924,000 | +56.6% | 45,579 | +70.7% | 0.00% | – |
Q2 2019 | $590,000 | +56.5% | 26,709 | -3.2% | 0.00% | – |
Q1 2019 | $377,000 | -56.6% | 27,595 | -71.3% | 0.00% | – |
Q4 2018 | $869,000 | +82.2% | 95,998 | +232.0% | 0.00% | – |
Q3 2018 | $477,000 | +3.5% | 28,919 | -12.1% | 0.00% | – |
Q2 2018 | $461,000 | +28.1% | 32,910 | +1.2% | 0.00% | – |
Q1 2018 | $360,000 | +58.6% | 32,526 | +26.2% | 0.00% | – |
Q4 2017 | $227,000 | +138.9% | 25,772 | +261.9% | 0.00% | – |
Q3 2017 | $95,000 | +97.9% | 7,122 | +109.6% | 0.00% | – |
Q2 2017 | $48,000 | +65.5% | 3,398 | +143.2% | 0.00% | – |
Q1 2017 | $29,000 | -48.2% | 1,397 | -29.4% | 0.00% | – |
Q4 2016 | $56,000 | -88.1% | 1,979 | -88.8% | 0.00% | – |
Q3 2016 | $471,000 | +4610.0% | 17,600 | +2833.3% | 0.00% | – |
Q2 2016 | $10,000 | -97.1% | 600 | -96.3% | 0.00% | – |
Q1 2016 | $344,000 | – | 16,200 | +107900.0% | 0.00% | – |
Q4 2015 | $0 | -100.0% | 15 | -98.6% | 0.00% | – |
Q3 2015 | $21,000 | -97.2% | 1,036 | -96.0% | 0.00% | -100.0% |
Q2 2015 | $746,000 | +74500.0% | 25,830 | +78172.7% | 0.00% | – |
Q4 2014 | $1,000 | – | 33 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |